We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
AVGR

Price
0.47
Stock movement up
+- (%)
Company name
Avinger Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
1.52M
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-75.81%
3 year return
-73.65%
5 year return
-67.71%
10 year return
-77.57%
Last updated: 2025-09-12

DIVIDENDS

AVGR does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.47
Daily high0.47
Daily low0.47
Daily Volume0K
All-time high2970000.00
1y analyst estimate5.00
Beta1.09
EPS (TTM)-
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
AVGRS&P500
Current price drop from All-time high-100.00%-
Highest price drop-100.00%-56.47%
Date of highest drop2 Jul 20259 Mar 2009
Avg drop from high-88.08%-10.99%
Avg time to new high153 days12 days
Max time to new high2378 days1805 days
COMPANY DETAILS
AVGR (Avinger Inc) company logo
Marketcap
1.52M
Marketcap category
Small-cap
Description
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.
Employees
68
Investor relations
-
SEC filings
CEO
Jeffrey M. Soinski
Country
USA
City
Redwood City
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner